EBGLYSS 250 mg/2mL (Lebrikizumab-Lbkz INJECTION, SOLUTION) 250 mg/2mL

EBGLYSS 250 mg/2mL is a subcutaneous injection solution containing lebrikizumab-lbkz. This medication is designed for specific therapeutic uses, offering a targeted approach to treatment. Learn more about its applications and effects.

Strength

250 mg/2mL

Pack Size

1 SYRINGE in 1 CARTON (0002-7772-11) / 2 mL in 1 SYRINGE (0002-7772-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EBGLYSS 250 mg/2mL is primarily used for the treatment of certain inflammatory conditions. It works by targeting specific pathways in the body to reduce inflammation and alleviate symptoms. People often ask, 'What is EBGLYSS used for?' This medication is typically prescribed for conditions that involve excessive immune responses, helping to manage and control symptoms effectively.

Side Effects

Common effects of EBGLYSS 250 mg/2mL may include localized reactions at the injection site, such as redness or mild discomfort. Some individuals might experience temporary systemic effects, but these are generally mild and short-lived. It's important to monitor any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

When handling EBGLYSS 250 mg/2mL, it's crucial to follow proper storage and administration guidelines. The medication should be stored at the recommended temperature to maintain its efficacy. Always use sterile techniques when preparing and administering the injection to minimize the risk of infection.

Avoid Interactions

EBGLYSS 250 mg/2mL may interact with certain medications, particularly those that affect the immune system. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that suppress the immune system should be used with caution.

Frequently Asked Questions

EBGLYSS is used to treat certain inflammatory conditions by targeting specific immune pathways.

EBGLYSS is administered via subcutaneous injection, typically by a healthcare professional.

Common side effects may include localized reactions at the injection site, such as redness or mild discomfort.

EBGLYSS may interact with certain medications, so it's important to consult a healthcare provider before combining treatments.

EBGLYSS should be stored at the recommended temperature to maintain its efficacy and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.